Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2003
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2003
Report date:
2003

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Deviations:
no
GLP compliance:
yes
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium dimethyldithiocarbamate
EC Number:
204-876-7
EC Name:
Sodium dimethyldithiocarbamate
Cas Number:
128-04-1
Molecular formula:
C3H7NS2.Na
IUPAC Name:
sodium dimethyldithiocarbamate

Test animals

Species:
mouse
Strain:
CD-1
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Ltd, Margate, Kent, UK
- Age at study initiation: 5-6 weeks
- Weight at study initiation: 24-29 g

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
purified water
Duration of treatment / exposure:
2 applications (total volume: 20 mL/kg bw)
Frequency of treatment:
24 h interval
Post exposure period:
24 h
Doses / concentrations
Remarks:
Doses / Concentrations:
350, 700, 1400 mg/kg bw
Basis:
nominal conc.
concentration in vehicle: 17.5, 35, 70 mg/mL
No. of animals per sex per dose:
6
Control animals:
yes
Positive control(s):
Cyclophosphamide (CP), 40 mg/kg bw

Examinations

Tissues and cell types examined:
- Tissue: Femoral bone marrow
- Type of cells: Erythrocytes (2000 cells per animal)
Evaluation criteria:
- Parameters: Micronucleated cells, ratio of poly- to normochromatic erythrocytes
Statistics:
Chi-square test

Results and discussion

Test results
Sex:
male
Genotoxicity:
negative
Toxicity:
yes
Remarks:
CLINICAL SIGNS - Eye closure and lethargy in all mice treated with 700 and 1400 mg/kg/day. Additionally, abnormal breathing and two mortalities in animals dosed with 1400 mg/kg/day.
Vehicle controls validity:
valid
Negative controls validity:
not applicable
Positive controls validity:
valid

Any other information on results incl. tables

Table 7.6.2-A1: Results for In Vivo Micronucleus Test

Treatment group

Dose [mg/kg/day]

PCE Scored

Mean Ratio PCE/NCE

MN PCE

MN PCE / 1000 cells ± sd b

Significance

vehicle

12000

1.07

8

0.67 ± 0.52

SDDC

350

12000

0.75

6

0.50 ± 0.45

NS

SDDC

700

12000

0.93

6

0.50 ± 0.55

NS

SDDC

1400

8000 b

0.55

4

0.50 ± 0.58

NS

Cyclophosphamide

40 a

12000

0.67

124

10.33 ± 3.83

p ≤ 0.05

a administered as a single dose

b animals found dead prior to dosing on day 2

sd standard deviation

MN micronucleated

NS not significant

Applicant's summary and conclusion